OpenURL Connection Search

Select item for more details and to access through your institution.

Abnormal vaginal bleeding as first symptom of acute leukemia.
Published in:
2001
By:
- Blaicher, W.;
- Jäger, U.;
- Jäger, U
Publication type:
journal article
Drug resistance factors in acute myeloid leukemia: a comparative analysis.
Published in:
2000
By:
- Filipits, M.;
- Stranzl, T.;
- Pohl, G.;
- Heinzl, H.;
- Jäger, U.;
- Geissler, K.;
- Fonatsch, C.;
- Haas, O.A.;
- Lechner, K.;
- Pirker, R.;
- Jäger, U
Publication type:
journal article
Fibrinolytic therapy with rt-PA in a patient with paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome.
Published in:
2003
By:
- Hauser, A. C.;
- Brichta, A.;
- Pabinger-Fasching, I.;
- Jäger, U.;
- Jäger, U
Publication type:
journal article
Fludarabine therapy in Waldenström's macroglobulinemia.
Published in:
2000
By:
- Thalhammer-Scherrer, R.;
- Geissler, K.;
- Schwarzinger, I.;
- Chott, A.;
- Gisslinger, H.;
- Knöbl, P.;
- Lechner, K.;
- Jäger, U.;
- Knöbl, P;
- Jäger, U
Publication type:
journal article
Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression.
Published in:
2006
By:
- Bilban, M.;
- Heintel, D.;
- Scharl, T.;
- Woelfel, T.;
- Auer, M. M.;
- Porpaczy, E.;
- Kainz, B.;
- Kröber, A.;
- Carey, V. J.;
- Shehata, M.;
- Zielinski, C.;
- Pickl, W.;
- Stilgenbauer, S.;
- Gaiger, A.;
- Wagner, O.;
- Jäger, U.;
- Kröber, A;
- Jäger, U;
- German CLL Study Group
Publication type:
journal article
RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
Published in:
2004
By:
- Schmidt, H. H.;
- Strehl, S.;
- Thaler, D.;
- Strunk, D.;
- Sill, H.;
- Linkesch, W.;
- Jäger, U.;
- Sperr, W.;
- Greinix, H. T.;
- König, M.;
- Emberger, W.;
- Haas, O. A.;
- Jäger, U;
- König, M
Publication type:
journal article
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis.
Published in:
Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 6, p. 1307, doi. 10.1007/s00432-016-2134-3
By:
- Rabitsch, W.;
- Bojic, M.;
- Wohlfarth, P.;
- Leiner, M.;
- Schörgenhofer, C.;
- Kalhs, P.;
- Schulenburg, A.;
- Sillaber, C.;
- Mitterbauer, M.;
- Sperr, W.;
- Jäger, U.;
- Skrabs, K.;
- Greinix, H.;
- Hermann, A.;
- Lamm, W.
Publication type:
Article
Chlorpromazine and Diltiazem Effects in Muscle: Blockage of Acetylcholine-Evoked Contractures, Membrane Currents and Tracer Calcium Uptake.
Published in:
Pharmacology, 1996, v. 53, n. 1, p. 11, doi. 10.1159/000139410
By:
- Lorković, H.;
- Jäger, U.
Publication type:
Article
Microscopic Structure of Semimagic Nuclei with 82 Neutrons or 50 Protons.
Published in:
Annalen der Physik, 1986, v. 498, n. 6-8, p. 424, doi. 10.1002/andp.19864980606
By:
- Enghardt, W.;
- Prade, H.;
- Jäger, H. U.;
- Käubler, L.;
- Keller, H.-J.;
- Stary, F.;
- Kostov, L. K.
Publication type:
Article
CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8+ cytotoxic T cells.
Published in:
2001
By:
- Selenko, N;
- Majdic, O;
- Draxler, S;
- Berer, A;
- Jäger, U;
- Knapp, W;
- Stöckl, J;
- Maidic, O;
- Draxier, S
Publication type:
journal article
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants.
Published in:
2001
By:
- Keil, F;
- Prinz, E;
- Kalhs, P;
- Lechner, K;
- Moser, K;
- Schwarzinger, I;
- Jäger, U;
- Fonatsch, C;
- Worel, N;
- Mannhalter, C;
- Rabitsch, W;
- Loidolt, H;
- Schulenburg, A;
- Mitterbauer, M;
- Höcker, P;
- Greinix, H T
Publication type:
journal article
Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
Published in:
2000
By:
- Königsberg, R;
- Ackermann, J;
- Kaufmann, H;
- Zojer, N;
- Urbauer, E;
- Krömer, E;
- Jäger, U;
- Gisslinger, H;
- Schreiber, S;
- Heinz, R;
- Ludwig, H;
- Huber, H;
- Drach, J
Publication type:
journal article
Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia.
Published in:
1998
By:
- Gaiger, A;
- Schmid, D;
- Heinze, G;
- Linnerth, B;
- Greinix, H;
- Kalhs, P;
- Tisljar, K;
- Priglinger, S;
- Laczika, K;
- Mitterbauer, M;
- Novak, M;
- Mitterbauer, G;
- Mannhalter, C;
- Haas, O A;
- Lechner, K;
- Jäger, U
Publication type:
journal article
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis.
Published in:
1998
By:
- Weltermann, A;
- Pabinger, I;
- Geissler, K;
- Jäger, U;
- Gisslinger, H;
- Knöbl, P;
- Eichinger, S;
- Kyrle, P A;
- Valent, P;
- Speiser, W;
- Schwarzinger, I;
- Mannhalter, C;
- Lechner, K
Publication type:
journal article
Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia.
Published in:
1997
By:
- Schmid, D;
- Heinze, G;
- Linnerth, B;
- Tisljar, K;
- Kusec, R;
- Geissler, K;
- Sillaber, C;
- Laczika, K;
- Mitterbauer, M;
- Zöchbauer, S;
- Mannhalter, C;
- Haas, O A;
- Lechner, K;
- Jäger, U;
- Gaiger, A
Publication type:
journal article
Is there a place for 2-CDA in the treatment of B-CLL?
Published in:
Leukemia (08876924), 1997, v. 11, p. S35
By:
- Mitterbauer, M.;
- Hilgenfeld, E.;
- Wilfing, A.;
- Jäger, U.;
- Knauf, Wu
Publication type:
Article
Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia.
Published in:
Journal of Clinical Pharmacy & Therapeutics, 2018, v. 43, n. 1, p. 145, doi. 10.1111/jcpt.12602
By:
- Skrabs, C.;
- Pickl, W. F.;
- Perkmann, T.;
- Jäger, U.;
- Gessl, A.
Publication type:
Article
Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo.
Published in:
Gene Therapy, 2000, v. 7, n. 5, p. 368, doi. 10.1038/sj.gt.3301093
By:
- Mavria, G;
- Jäger, U;
- Porter, C D
Publication type:
Article
Induction of complement attack on human cells by Gal(alpha1,3)Gal xenoantigen expression as a gene therapy approach to cancer.
Published in:
Gene Therapy, 1999, v. 6, n. 6, p. 1073
By:
- Jäger, U;
- Takeuchi, Y;
- Porter, C D
Publication type:
Article
Sotalol-induced torsades de pointes in a patient with pre-existent normal response to programmed ventricular stimulation.
Published in:
European Heart Journal, 1987, v. 8, n. 12, p. 1351, doi. 10.1093/oxfordjournals.eurheartj.a062223
By:
- GÖSSINGER, H. D.;
- SIOSTRZONEK, P.;
- SCHMOLINER, R.;
- GRIMM, G.;
- JÄGER, U.;
- MÖSSLACHER, H.
Publication type:
Article
Sotalol-induced torsades de pointes in a patient with pre-existent normal response to programmed ventricular stimulation.
Published in:
European Heart Journal, 1987, v. 8, n. 7, p. 1351, doi. 10.1093/oxfordjournals.eurheartj.a062223
By:
- GÖSSINGER, H. D.;
- SIOSTRZONEK, P.;
- SCHMOLINER, R.;
- GRIMM, G.;
- JÄGER, U.;
- MÖSSLACHER, H.
Publication type:
Article
ANALYSE DER NARKOTISIERUNGSTIEFE AUF DER BASIS IIIRNELEKTRISCHER POTENTIALE DURCH NEURONALE NETZE WÄHREND AMBULANTER OPERATIONEN.
Published in:
Biomedical Engineering / Biomedizinische Technik, 2003, v. 48, p. 260, doi. 10.1515/bmte.2003.48.s1.260
By:
- Wenzel, A.;
- ßaumgart-Schmitt, R.;
- Jäger, U.
Publication type:
Article
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis.
Published in:
Annals of Hematology, 2002, v. 81, n. 2, p. 90, doi. 10.1007/s00277-001-0412-9
By:
- Agis, H.;
- Weltermann, A.;
- Fonatsch, C.;
- Haas, O.;
- Mitterbauer, G.;
- Müllauer, L.;
- Schreiber, S.;
- Schwarzinger, I.;
- Juretzka, W.;
- Valent, P.;
- Jäger, U.;
- Lechner, K.;
- Geissler, K.
Publication type:
Article
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia.
Published in:
2000
By:
- Greinix, H. T.;
- Loidolt, H.;
- Rabitsch, W.;
- Schulenburg, A.;
- Keil, F.;
- Mitterbauer, M.;
- Laczika, K.;
- Lechner, K.;
- Dieckmann, K.;
- Fischer, G.;
- Jäger, U.;
- Rosenmayr, A.;
- Knöbl, P.;
- Schwarzinger, I.;
- Höcker, P.;
- Mannhalter, C.;
- Hinterberger, W.;
- Haas, O. A.;
- Fonatsch, C.;
- Kalhs, P.
Publication type:
journal article
Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily.
Published in:
European Journal of Clinical Investigation, 2009, v. 39, n. 12, p. 1098, doi. 10.1111/j.1365-2362.2009.02206.x
By:
- Sillaber, C.;
- Herrmann, H.;
- Bennett, K.;
- Rix, U.;
- Baumgartner, C.;
- Böhm, A.;
- Herndlhofer, S.;
- Tschachler, E.;
- Superti-Furga, G.;
- Jäger, U.;
- Valent, P.
Publication type:
Article
Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology.
Published in:
European Journal of Clinical Investigation, 2009, v. 39, n. 10, p. 914, doi. 10.1111/j.1365-2362.2009.02184.x
By:
- Sperr, W. R.;
- El-Samahi, A.;
- Kundi, M.;
- Girschikofsky, M.;
- Winkler, S.;
- Lutz, D.;
- Endler, G.;
- Rumpold, H.;
- Agis, H.;
- Sillaber, C.;
- Jäger, U.;
- Valent, P.
Publication type:
Article
Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.
Published in:
European Journal of Clinical Investigation, 2009, v. 39, n. 6, p. 497, doi. 10.1111/j.1365-2362.2009.02131.x
By:
- Steininger, C.;
- Rassenti, L. Z.;
- Vanura, K.;
- Eigenberger, K.;
- Jäger, U.;
- Kipps, T. J.;
- Mannhalter, C.;
- Stilgenbauer, S.;
- Popow-Kraupp, T.
Publication type:
Article
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.
Published in:
European Journal of Clinical Investigation, 2007, v. 37, n. 10, p. 808, doi. 10.1111/j.1365-2362.2007.01859.x
By:
- Aichberger, K. J.;
- Herndlhofer, S.;
- Agis, H.;
- Sperr, W. R.;
- Esterbauer, H.;
- Rabitsch, W.;
- Knöbl, P.;
- Haas, O. A.;
- Thalhammer, R.;
- Schwarzinger, I.;
- Sillaber, C.;
- Jäger, U.;
- Valent, P.
Publication type:
Article
Novel molecular diagnostic and therapeutic targets in chronic lymphocytic leukaemia.
Published in:
European Journal of Clinical Investigation, 2004, v. 34, p. 25, doi. 10.1111/j.0960-135X.2004.01367.x
By:
- Gaiger, A.;
- Heintel, D.;
- Jäger, U.
Publication type:
Article
Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia.
Published in:
2010
By:
- Shehata, M.;
- Demirtas, D.;
- Schnabl, S.;
- Hilgarth, M.;
- Hubmann, R.;
- Fonatsch, C.;
- Schwarzinger, I.;
- Hopfinger, G.;
- Eigenberger, K.;
- Heintel, D.;
- Porpaczy, E.;
- Vanura, K.;
- Hauswirth, A.;
- Schwarzmeier, J. D.;
- Gaiger, A.;
- Stilgenbauer, S.;
- Hallek, M.;
- Bilban, M.;
- Jäger, U.
Publication type:
Letter
Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma.
Published in:
2008
By:
- Heintel, D.;
- Zojer, N.;
- Schreder, M.;
- Strasser-Weippl, K.;
- Kainz, B.;
- Vesely, M.;
- Gisslinger, H.;
- Drach, J.;
- Gaiger, A.;
- Jäger, U.;
- Ludwig, H.
Publication type:
Letter
Remission of pure red cell aplasia in T-cell receptor γδ-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab.
Published in:
2005
By:
- Schützinger, C.;
- Gaiger, A.;
- Thalhammer, R.;
- Vesely, M.;
- Fritsche-Polanz, R.;
- Schwarzinger, I.;
- Öhler, L.;
- Simonitsch-Klupp, I.;
- Reinhard, F.;
- Jäger, U.
Publication type:
Letter
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.
Published in:
Leukemia (08876924), 2005, v. 19, n. 7, p. 1216, doi. 10.1038/sj.leu.2403748
By:
- Heintel, D.;
- Kienle, D.;
- Shehata, M.;
- Kröber, A.;
- Kroemer, E.;
- Schwarzinger, I.;
- Mitteregger, D.;
- Le, T.;
- Gleiß, A.;
- Mannhalter, C.;
- Chott, A.;
- Schwarzmeier, J.;
- Fonatsch, C.;
- Gaiger, A.;
- Döhner, H.;
- Stilgenbauer, S.;
- Jäger, U.
Publication type:
Article
Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
Published in:
Leukemia (08876924), 2004, v. 18, n. 11, p. 1879, doi. 10.1038/sj.leu.2403518
By:
- Kaufmann, H;
- Ackermann, J;
- Baldia, C;
- Nösslinger, T;
- Wieser, R;
- Seidl, S;
- Sagaster, V;
- Gisslinger, H;
- Jäger, U;
- Pfeilstöcker, M;
- Zielinski, C;
- Drach, J
Publication type:
Article
High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia.
Published in:
Leukemia (08876924), 2004, v. 18, n. 4, p. 756, doi. 10.1038/sj.leu.2403294
By:
- Heintel, D.;
- Kroemer, E.;
- Kienle, D.;
- Schwarzinger, I.;
- Gleiß, A.;
- Schwarzmeier, J.;
- Marcuiescu, R.;
- Le, T.;
- Mannhalter, C.;
- Gaiger, A.;
- Stilgenbauer, S.;
- Döhner, H.;
- Fonatsch, C.;
- Jäger, U.
Publication type:
Article
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse.
Published in:
Leukemia (08876924), 2004, v. 18, n. 2, p. 293, doi. 10.1038/sj.leu.2403243
By:
- Weltermann, A.;
- Fonatsch, C.;
- Haas, O.A.;
- Greinix, H.T.;
- Kahls, P.;
- Mitterbauer, G.;
- Jäger, U.;
- Kainz, B.;
- Geissler, K.;
- Valent, P.;
- Sperr, W.R.;
- Knöbl, P.;
- Schwarzinger, I.;
- Gleiß, A.;
- Lechner, K.
Publication type:
Article
A RANDOMIZED PHASE II STUDY OF MB‐CART2019.1 COMPARED TO STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR ASCT – DALY 2‐EU TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 840, doi. 10.1002/hon.3166_OT20
By:
- Borchmann, P.;
- Vandenberghe, P.;
- Urbano‐Ispizua, A.;
- Haiuon, C.;
- Griškevicius, L.;
- Lemonnier, F.;
- Zadoyan, G.;
- Bethke, U.;
- Overstijns, T.;
- Hanssens, L.;
- Bürger, I.;
- Assenmacher, M.;
- Reer, O.;
- Friedrichs, B.;
- Holtkamp, S.;
- Jäger, U.;
- Kersten, M. J.
Publication type:
Article
Imatinib‐induced complete and long‐term sustained remission in chemotherapy‐resistant systemic ALK‐positive anaplastic large cell lymphoma.
Published in:
Hematological Oncology, 2023, v. 41, p. 504, doi. 10.1002/hon.3164_372
By:
- Pichler, A.;
- Kornauth, C.;
- Garces‐de‐los‐Fayos‐Alonso, I.;
- Kazianka, L.;
- Alachram, H.;
- Zibat, A.;
- Pemovska, T.;
- Heller, G.;
- Greil, R.;
- Kenner, L.;
- Jäger, U.;
- Staber, P.
Publication type:
Article
SINGLE‐CELL RNA‐SEQ OF CLASSIC HAIRY CELL LEUKEMIA REVEALS DISEASE DRIVERS LINKED TO INTRINSIC TREATMENT RESISTANCE AND IDENTIFIES DUSP1 AS POTENTIAL NEW THERAPEUTIC TARGET.
Published in:
Hematological Oncology, 2023, v. 41, p. 187, doi. 10.1002/hon.3163_117
By:
- Bohn, J.;
- Salcher, S.;
- Sturm, G.;
- Kugler, V.;
- Feichtner, A.;
- Fritz, A.;
- Torres‐Quesada, O.;
- Mair, A.;
- Scheiber, A.;
- Jäger, U.;
- Brunner, A.;
- Pircher, A.;
- Sopper, S.;
- Stefan, E.;
- Trajanoski, Z.;
- Wolf, D.
Publication type:
Article
THE CLL‐RT1 TRIAL: A MULTICENTER PHASE‐2 TRIAL OF ZANUBRUTINIB, A BTK INHIBITOR, PLUS TISLELIZUMAB, A PD‐1 INHIBITOR, FOR PATIENTS WITH RICHTER TRANSFORMATION.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.161_2880
By:
- Al‐Sawaf, O.;
- Robrecht, S.;
- Stumpf, J.;
- Fink, A.‐M.;
- Ritgen, M.;
- Johansson, P.;
- Tausch, E.;
- Hoechstetter, M.;
- Staber, P.;
- Jäger, U.;
- Niemann, C. U.;
- Pallasch, C.;
- Kreuzer, K.‐A.;
- Stilgenbauer, S.;
- Fischer, K.;
- Wendtner, C.;
- Hallek, M.;
- Eichhorst, B.
Publication type:
Article
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R2‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
Published in:
Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.93_2629
By:
- Nowakowski, G.;
- Willenbacher, W.;
- Greil, R.;
- Larsen, T.S.;
- Patel, K.;
- Jäger, U.;
- Manges, R.F.;
- Trümper, L.;
- Haioun, C.;
- Everaus, H.;
- Kalakonda, N.;
- Knoble, J.;
- Nully Brown, P.;
- Jørgensen, J.M.;
- Cunningham, D.;
- Domper Rubio, N.;
- Casadebaig, M.;
- Manzke, O.;
- Munoz, J.
Publication type:
Article
UNMAINTAINED REMISSION AFTER DISCONTINUATION OF KINASE INHIBITOR TREATEMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: AN OBSERVATIONAL COHORT.
Published in:
Hematological Oncology, 2019, v. 37, p. 218, doi. 10.1002/hon.33_2630
By:
- Egle, A.;
- Jäger, U.;
- Skrabs, C.;
- Dürig, J.;
- Nösslinger, T.;
- Wanner, D.;
- Steurer, M.;
- Ringshausen, I.;
- Melchardt, T.;
- Greil, R.;
- Ysebaert, L.
Publication type:
Article
EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 214, doi. 10.1002/hon.30_2630
By:
- Ghia, P.;
- Flinn, I.W.;
- Lamanna, N.;
- Montillo, M.;
- Illés, Á.;
- Etienne, G.;
- Delgado, J.;
- Kuss, B.J.;
- Tam, C.S.;
- Offner, F.;
- Bosch, F.;
- Davids, M.S.;
- Jäger, U.;
- Cymbalista, F.;
- Weaver, D.T.;
- Lustgarten, S.;
- Youssoufian, H.;
- Stilgenbauer, S.
Publication type:
Article
AN IMPROVED BENEFIT‐RISK PROFILE OF DUVELISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WHO RECEIVED 2 OR MORE PRIOR THERAPIES.
Published in:
Hematological Oncology, 2019, v. 37, p. 213, doi. 10.1002/hon.29_2630
By:
- Flinn, I.W.;
- Davids, M.S.;
- Hillmen, P.;
- Montillo, M.;
- Delgado, J.;
- Kuss, B.J.;
- Tam, C.S.;
- Jäger, U.;
- Ghia, P.;
- Stilgenbauer, S.;
- Lustgarten, S.;
- Weaver, D.T.;
- Youssoufian, H.;
- Cymbalista, F.
Publication type:
Article
THE COMBINATION OF VENETOCLAX AND IBRUTINIB IS EFFECTIVE IN RELAPSED/REFRACTORY T‐PROLYMPHOCYTIC LEUKEMIA AND INFLUENCES BCL‐2‐FAMILY MEMBER DEPENDENCIES.
Published in:
Hematological Oncology, 2019, v. 37, p. 482, doi. 10.1002/hon.161_2631
By:
- Kornauth, C.F.;
- Herbaux, C.;
- Boidol, B.;
- Guillemette, C.;
- Mayerhöfer, M.E.;
- Jäger, U.;
- Kubicek, S.;
- Davids, M.S.;
- Staber, P.B.
Publication type:
Article
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R2‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
Published in:
Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.93_2629
By:
- Nowakowski, G.;
- Willenbacher, W.;
- Greil, R.;
- Larsen, T.S.;
- Patel, K.;
- Jäger, U.;
- Manges, R.F.;
- Trümper, L.;
- Haioun, C.;
- Everaus, H.;
- Kalakonda, N.;
- Knoble, J.;
- Nully Brown, P.;
- Jørgensen, J.M.;
- Cunningham, D.;
- Domper Rubio, N.;
- Casadebaig, M.;
- Manzke, O.;
- Munoz, J.
Publication type:
Article
UNMAINTAINED REMISSION AFTER DISCONTINUATION OF KINASE INHIBITOR TREATEMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: AN OBSERVATIONAL COHORT.
Published in:
Hematological Oncology, 2019, v. 37, p. 218, doi. 10.1002/hon.33_2630
By:
- Egle, A.;
- Jäger, U.;
- Skrabs, C.;
- Dürig, J.;
- Nösslinger, T.;
- Wanner, D.;
- Steurer, M.;
- Ringshausen, I.;
- Melchardt, T.;
- Greil, R.;
- Ysebaert, L.
Publication type:
Article
EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 214, doi. 10.1002/hon.30_2630
By:
- Ghia, P.;
- Flinn, I.W.;
- Lamanna, N.;
- Montillo, M.;
- Illés, Á.;
- Etienne, G.;
- Delgado, J.;
- Kuss, B.J.;
- Tam, C.S.;
- Offner, F.;
- Bosch, F.;
- Davids, M.S.;
- Jäger, U.;
- Cymbalista, F.;
- Weaver, D.T.;
- Lustgarten, S.;
- Youssoufian, H.;
- Stilgenbauer, S.
Publication type:
Article
AN IMPROVED BENEFIT‐RISK PROFILE OF DUVELISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WHO RECEIVED 2 OR MORE PRIOR THERAPIES.
Published in:
Hematological Oncology, 2019, v. 37, p. 213, doi. 10.1002/hon.29_2630
By:
- Flinn, I.W.;
- Davids, M.S.;
- Hillmen, P.;
- Montillo, M.;
- Delgado, J.;
- Kuss, B.J.;
- Tam, C.S.;
- Jäger, U.;
- Ghia, P.;
- Stilgenbauer, S.;
- Lustgarten, S.;
- Weaver, D.T.;
- Youssoufian, H.;
- Cymbalista, F.
Publication type:
Article
THE COMBINATION OF VENETOCLAX AND IBRUTINIB IS EFFECTIVE IN RELAPSED/REFRACTORY T‐PROLYMPHOCYTIC LEUKEMIA AND INFLUENCES BCL‐2‐FAMILY MEMBER DEPENDENCIES.
Published in:
Hematological Oncology, 2019, v. 37, p. 482, doi. 10.1002/hon.161_2631
By:
- Kornauth, C.F.;
- Herbaux, C.;
- Boidol, B.;
- Guillemette, C.;
- Mayerhöfer, M.E.;
- Jäger, U.;
- Kubicek, S.;
- Davids, M.S.;
- Staber, P.B.
Publication type:
Article

Found: 56